Contact

About
Food Allergies and Our Approach
- Food Allergies Overview
- Our Approach and Platform
Programmes and Clinical Trials
News & Events
- News
- Events
- In the News
Menu Menu

Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

3 August 2026

Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

DiscoverPharma
3 August 2026

https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png 0 0 Admin https://www.aravax.com.au/wp-content/uploads/2025/09/logo-Aravax_REV.png Admin2026-08-03 08:00:402026-09-03 13:20:47Aravax’s PVX108 wins FDA Fast Track designation for peanut allergy

© Aravax

Contact Us

Email: info@aravax.com.au

Australia

Level 9, 31 Queen St, Melbourne, Victoria, 3000 Australia
Tel: +61 (0)3 9657 0700

UK

John Eccles House, Oxford Science Park
Oxford, OX4 4GP, United Kingdom

Aravax’s Allergy Shot Gains FDA Fast Track, Fueling Race for a Cure Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy...